The Sharemaestro Review
Latest Sharemaestro market news for US Drug Manufacturers - General stocks, compared with the broader Healthcare sector.
Featured analysis · Healthcare · AMGN
AMGN added 2.4% in the week to 31 July and sits only 3.2% below its 52-week high, with the Trend Signal active but volume confirmation still modest.
Current setup
Balanced readOverall score 67/100Latest company research
Price action in context—what moved, what confirmed it, and what still needs proving.
Healthcare Drug Manufacturers - General
BIIB rose 3.4% in the latest week on nearly double its 13-week volume, keeping a 45-week Trend Signal intact while Healthcare breadth remains selective.
Healthcare Drug Manufacturers - General
JNJ slipped 1.5% in the latest week, but the broader profile remains constructive, with the stock still 8.7% above its weekly Trend Line and 85.2% through its 52-week range.
Healthcare Drug Manufacturers - General
ABBV closed within 0.2% of its 52-week high after a 14.9% four-week run, but the latest advance came on 0.9x volume and leaves valuation distance stretched.
Healthcare Drug Manufacturers - General
LLY finished at $1,208 after a strong week on above-average participation, but the stock now sits 51.1% above Sharemaestro Fair Value as Healthcare breadth remains selective.
Healthcare Drug Manufacturers - General
Novartis outpaced its drugmaker group for the week on heavy volume, yet the broader confirmation picture is mixed as Market Dynamics remains below zero.
Healthcare Drug Manufacturers - General
MRK closed at $128.70 after a high-range advance on 64.4M shares, with the weekly Trend Signal still active but Market Dynamics short of a fresh buy confirmation.
Healthcare Drug Manufacturers - General
JNJ jumped 11.5% to finish just 0.2% below its 52-week high, but negative activity pressure and a 52% Fair Value premium keep the weekly setup from being one-sided.
Search by ticker symbol or company name and select a result to open its chart.